U.S. officials declare monkeypox a public health emergency

Although the number of cases of monkeypox in the country has surpassed 6,600, officials are still optimistic that the outbreak can be contained with more immunizations and testing.

As the number of cases nationally surpassed 6,600, the Biden administration proclaimed monkeypox a public health emergency on Thursday.
The declaration may make it simpler to obtain emergency financing, enable health organisations to gather more information about cases and vaccinations, hasten the distribution of vaccines, and make it simpler for physicians to provide remedies.
At a briefing on the emergency declaration on Thursday, Secretary of Health and Human Services Xavier Becerra said, “We’re ready to take our response to the next level in addressing this virus and we urge every American to take monkeypox seriously and to take responsibility to help us tackle this virus.”
New York state, which declared a state of emergency last week, accounts for 25% of cases in the United States. Illinois and California declared states of emergency on Monday.

Monkeypox was designated a public health emergency of international concern by the World Health Organization last month, a classification saved for the most severe global disease outbreaks. It has been used in the past to treat cases of CoViD-19, Zika, H1N1, polio, and Ebola. According to the Centers for Disease Control and Prevention, there have been at least 26,200 confirmed cases of monkeypox this year.
Male-to-male sexual intercourse is the primary method of transmission for monkeypox, which was not the case during earlier virus outbreaks. According to a report released last week by the Department of Health and Human Services, all but one percent of the instances of monkeypox in the United States thus far have been in male babies.
The WHO recently encouraged males who have sex with men to cut back on the number of partners they have and think twice before having sex with anyone new while the outbreak is still going on.
People of all ages can contract monkeypox in the United States, but the average patient is around 35 years old. Five cases of paediatric infections have been reported by the CDC: two in California, two in Indiana, and one infant who is not a citizen of the United States but tested positive in Washington, D.C.
However, Jennifer Rice Epstein, the public affairs officer at the Long Beach Department of Health and Human Services, claimed the patient in her city was exposed via a close contact. The health authorities of California and Indiana declined to share specifics about their paediatric cases.
According to HHS, as of last week, white individuals made up 37% of cases of monkeypox in the United States, followed by Hispanic or Latino people (31%), Black people (27%), and Asian people (4%).

U.S. authorities continue to believe that the outbreak can be stopped.

HHS authorities are still working to keep monkeypox from spreading around the country.
Becerra stated on Thursday, “We continue to mobilise the resources needed to ensure that we can combat monkeypox and prevent it from spreading to the point of becoming endemic.
If we all cooperate, “there should be no reason why we can’t keep ahead of this,” he continued.

Testing, specialised immunizations, and therapy are the mainstays of this endeavour.
Of the 1.1 million Jynneos vaccine doses that are still available as of Thursday, the United States had given out 600,000 of them. The vaccine is given as a two-shot course of treatment. 6.9 million doses have been ordered nationwide. According to HHS, a cargo containing 150,000 pills will reach the country in September and be given out.
If administered before or within four days of exposure, the shot can prevent monkeypox. It can lessen symptoms if administered within 14 days of exposure.
Additionally, there are currently 80,000 weekly tests available in the United States as opposed to 6,000 in May.
“We are actually just testing at roughly 10% of our current capability. We urge anyone who thinks they may have monkeypox to come in for testing “On Thursday, CDC Director Rochelle Walensky stated.

TPOXX is an antiviral medication that is approved for use against smallpox but can also be used to treat monkeypox, and it has been administered to roughly 14,000 people in the United States. According to HHS, 1.7 million of the medications are present in the Strategic National Stockpile. However, for the time being, the medicine is only prescribed to those who have severe illness or a significant risk of developing severe illness. To prescribe it for monkeypox, doctors must also undergo a lengthy paperwork process.
One of the main reasons why sexual health professionals urged HHS to issue a public health emergency was the increased accessibility to TPOXX.
David Harvey, executive director of the National Coalition of STD Directors, said in a news call on Tuesday that it would be “unconscionable” to not continue to make reforms to make TPOXX accessible to everyone who needs it.

Most Americans with monkeypox have reported having a rash.

The majority of cases of monkeypox in the United States have so far been associated with a rash, along with malaise, fever, and enlarged lymph nodes. Chills, headaches, and muscle soreness have also been mentioned by some patients.
According to the WHO, some individuals with monkeypox may experience one or two lesions in their rash, while others may experience thousands.
A research that looked at instances of monkeypox in 16 countries from April to June and was released last month discovered that over 65% of participants had less than 10 lesions. The genital or anus region was the location of the lesions most frequently, followed by the thorax, arms, or legs. Lesions on the face, palms, or soles of the feet were more rarely observed.
According to the study, symptoms usually started to manifest a week after exposure. In the study, 13% of participants were hospitalised, primarily for pain management.

Scroll to Top